Neogene Therapeutics develops innovative cell therapies for the treatment of cancer. By harnessing the power of T cells—an integral part of the immune system—Neogene creates engineered T cell solutions tailored to target specific tumors, with the goal of improving patient outcomes. The company is committed to advancing its pipeline of therapies through rigorous research and clinical trials, aiming to offer new hope to cancer patients. With a focus on collaboration and scientific excellence, Neogene values integrity, respect, and a dedication to making a meaningful impact in the fight against cancer.